The 2026 ADA guidelines suggest a promising role for these drugs in selected adults with type 1 diabetes and obesity
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Kober LV, Lawson FC, Ping L, Wei X, Lewis EF, et al
Medical therapy Medical therapy has traditionally involved agonists of the physiologic inhibitor of prolactin, dopamine (Box 3, Table 1)
New insights on consumers preferences on the texture of protein snacks create new opportunities for CPG companies Protein texture preferences Only about half of GLP-1 users are satisfied with protein options
Sulforaphane as a potential remedy against cancer: comprehensive mechanistic review
It is an 83-residue recombinant protein, made by expressing an engineered gene in Escherichia coli and purifying the product, not by solid-phase chemical synthesis